DNAAF1 Gene Primary Ciliary Dyskinesia Type 13 Genetic Test sale cost 4400 AED
SERPINB6 Gene Deafness Autosomal Recessive Type 91 Genetic Test sale cost 4400 AED SERPINB6 Gene Deafness Autosomal Recessive Type 91 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
DNAAF5 Gene Primary Ciliary Dyskinesia Type 18 Genetic Test sale cost 4400 AED DNAAF5 Gene Primary Ciliary Dyskinesia Type 18 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

DNAAF1 Gene Primary Ciliary Dyskinesia Type 13 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The DNAAF1 gene primary ciliary dyskinesia type 13 genetic test is a specialized diagnostic examination designed to identify mutations in the DNAAF1 gene, which are associated with primary ciliary dyskinesia (PCD) type 13. This condition is a rare genetic disorder characterized by abnormalities in the structure and function of cilia, leading to chronic respiratory tract infections, reduced fertility, and, in some cases, laterality defects. The test is crucial for accurate diagnosis, enabling targeted management and counseling for affected individuals and their families.

Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves collecting a DNA sample, usually through a blood draw or cheek swab, and analyzing it for specific genetic alterations in the DNAAF1 gene. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the advanced technology employed.

By providing a definitive diagnosis, the DNAAF1 gene primary ciliary dyskinesia type 13 genetic test plays a vital role in the care and treatment of patients with this condition, guiding therapeutic decisions and offering insight into the genetic basis of the disorder.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

DNAAF1 Gene Primary ciliary dyskinesia type 13 Genetic Test

At DNA Labs UAE, we offer the DNAAF1 Gene Primary ciliary dyskinesia type 13 Genetic Test. This test is designed to detect genetic mutations or variations in the DNAAF1 gene, which is associated with primary ciliary dyskinesia type 13. Primary ciliary dyskinesia is a rare genetic disorder that affects the function of cilia in the respiratory tract. Cilia are hair-like structures that help move mucus and other substances out of the airways.

Test Components

  • Test Name: DNAAF1 Gene Primary ciliary dyskinesia type 13 Genetic Test
  • Price: 4400.0 AED

Sample Condition

The sample condition required for this test is either blood, extracted DNA, or one drop of blood on an FTA card.

Report Delivery

The report for the DNAAF1 Gene Primary ciliary dyskinesia type 13 Genetic Test will be delivered within 3 to 4 weeks.

Method

The test utilizes NGS (Next-Generation Sequencing) technology for analysis.

Test Type

The DNAAF1 Gene Primary ciliary dyskinesia type 13 Genetic Test falls under the category of Ear Nose Throat Disorders.

Doctor

This test is recommended to be conducted by an ENT Doctor.

Test Department

The DNAAF1 Gene Primary ciliary dyskinesia type 13 Genetic Test is conducted in the Genetics department.

Pre Test Information

Before undergoing the DNAAF1 Gene Primary ciliary dyskinesia type 13 Genetic Test, it is important to provide the clinical history of the patient. This test is specifically recommended for individuals who are also going for the SLC52A3 Gene Brown-Vialetto-Van Laere syndrome 1 NGS Genetic DNA Test. Additionally, a genetic counseling session is conducted to draw a pedigree chart of family members affected by the SLC52A3 Gene Brown-Vialetto-Van Laere syndrome 1 NGS Genetic DNA Test gene SLC52A18.

Test Details

The DNAAF1 gene is associated with primary ciliary dyskinesia type 13. NGS genetic testing is used to analyze multiple genes simultaneously. In the case of primary ciliary dyskinesia, NGS genetic testing can identify mutations or variations in the DNAAF1 gene, aiding in diagnosis, genetic counseling, and treatment decisions.

Test Name DNAAF1 Gene Primary ciliary dyskinesia type 13 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ear Nose Throat Disorders
Doctor ENT Doctor
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SLC52A3 Gene Brown-Vialetto-Van Laere syndrome 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC52A3 Gene Brown-Vialetto-Van Laere syndrome 1 NGS Genetic DNA Test gene SLC52A18
Test Details

The DNAAF1 gene is associated with primary ciliary dyskinesia type 13, which is a rare genetic disorder that affects the function of cilia in the respiratory tract. Cilia are hair-like structures that help move mucus and other substances out of the airways.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the context of primary ciliary dyskinesia, NGS genetic testing can be used to identify mutations or variations in the DNAAF1 gene that may be causing the disorder. This can help with diagnosis, genetic counseling, and potentially guide treatment decisions.

SKU: TEST-2770 Category:

Related products